What is the current GLP-1 agonists commercial assessment
Currently, there are two main types of drug therapy used to treat melanoma: Targeted therapy BRAF inhibitors: dabrafenib and vemurafenib MEK inhibitors: trametinib Combination BRAF and MEK inhibitors: dabrafenib C-KIT inhibitors: imatinib, nilotinib Immunotherapy/immune-modulating therapy PD-1 antagonist: pembrolizumab and nivolumab PD-L1: atezolizumab CTLA-4 antagonist: ipilimumab LAG-3 inhibitor: relatlimab Interleukin-2 (IL-2) Interferon alfa 2b Chimeric antigen receptor T cell therapy (CAR-T) Imiquimod Oncolytic virus - Talimogene laherparepvec (Imlygic) For a more detailed summary of the immunotherapy agents currently available, see the Cancer Research Institute website
Glutathione IV Infusion Empowers cells, slows down aging and produces a brighter, healthier skin glow.
Int J Mol Sci 24(12):10309
Zhuang J, Zhang J, Lwin ST, Edwards JR, Edwards CM, Mundy GR, et al
The doses approved by regulatory bodies have been determined through rigorous phase III clinical trials involving thousands of participants, with careful assessment of both efficacy and safety profiles
